drugset / Trial / NCT01490658

Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy Volunteers

NCT01490658

Phase 1 Completed 93 enrolled Novo Nordisk A/S
RandomizedCrossoverSingle-blindTreatment

Summary

This trial is conducted in the United States of America (USA). The aim of this trial is to compare repaglinide and metformin as co-administered tablets and as a combination tablet.

Timeline

Start
2006-06
Primary completion
2006-08
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg
Subject Repaglinide Small molecule 1 mg
Subject Repaglinide Small molecule 2 mg